Red Light Therapy for Cardiovascular aging
Long-term full-body PBM (850 nm; 25 mW/cm2; 120 sec; each weekday) improved several age-related cardiovascular changes in AC8 overexpressing 14-month old mice over a 8-month period (Syed et al. 2023): ● PBM reduced age-related increase in left ventricular (LV) mass, LV end-diastolic volume and aortic wall stiffness ● PBM increased LV ejection fraction, gait symmetry and serum levels of TGF-β1 ● Survival was increased (100%) compared to untreated mice (43%)
Evidence Summary
1 animal study (mouse)
Related Conditions in Cardiology and hematology
Research Basis
This content is informed by 47+ published peer-reviewed studies on photobiomodulation.
RedLightOS Research Team
Photobiomodulation Research
The RedLightOS team reviews over 9,500 published photobiomodulation studies to deliver evidence-based red light therapy guidance.
Reviewed by RedLightOS Research Team. Last reviewed: . Based on published photobiomodulation research. For educational purposes only — not a substitute for professional medical advice. See our methodology.
Medical Disclaimer: This content is for informational and educational purposes only. It is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Red light therapy devices are wellness devices and are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary.